IRAK4 in TLR/IL-1R signaling: Possible clinical applications

European Journal of Immunology

Volumn 38, Issue 3, 2008, Pages 614-618

  Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Inflammation; IRAK; NF B pathway; TLR

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; BETA INTERFERON; CHEMOKINE; CPG OLIGODEOXYNUCLEOTIDE; CXCL1 CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4 INHIBITOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; RESIQUIMOD; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK4 PROTEIN, HUMAN; IRAK4 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC STABILITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; NOTE; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICE; PROTEIN KINASE INHIBITORS; RECEPTORS, INTERLEUKIN-1; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 43649094012     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200838161     Document Type: Article

References (30)

1. Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K. et al., Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005. 6: 1087-1095.
2. Shim, J. H., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K. Y. et al., TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005. 19: 2668-2681.
3. Yao, J., Kim, T., Qin, J., Jiang, Z., Qian, Y., Xiao, H., Lu, Y. et al., Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J. Biol. Chem. 2007. 282: 6075-6089.
4. Akira, S., Takeda, K., and Kaisho, T., Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001. 2: 675-680.
5. Cao, Z., Xiong, J., Takeuchi,M., Kurama, T., and Goeddel, D. V., TRAF6 is a signal transducer for interleukin-1. Nature 1996. 383: 443-446.
6. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C. et al., Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000. 103: 351-361.
7. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K., The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999. 398: 252-256.
8. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K. et al., Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004. 5: 1061-1068.
9. Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y. et al., Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004. 101: 15416-15421.
10. Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M. et al., Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 2005. 201: 915-923.
11. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S., Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999. 11: 115-122.
12. Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P. F., and Akira, S., Cutting edge: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 2000. 164: 554-557.
13. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O. et al., Role of Adapter TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003. 301: 640-643.
14. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J. et al., Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003. 424: 743-748.
15. Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O. et al., TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 2003. 4: 1144-1150.
16. Kim, T. W., Staschke, K., Bulek, K., Yao, J., Peters, K., Oh, K. H., Vandenburg, Y. et al., A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 2007. 204: 1025-1036.
17. Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S. et al., Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J. Exp. Med. 2007. 204: 1013-1024.
18. Koziczak-Holbro, M., Joyce, C., Gluck, A., Kinzel, B., Muller, M., Tschopp, C., Mathison, J. C, et al., IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J. Biol. Chem. 2007. 282: 13552-13560.
19. Koziczak-Holbro, M., Gluck, A., Tschopp, C., Mathison, J. C., and Gram, H., IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur. J. Immunol. 2008. 38: DOI 10.1002/eji.200737886.
20. Qin, J., Jiang, Z., Qian, Y., Casanova,.J. L., and Li, X., IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J. Biol. Chem. 2004. 279: 26748-26753.
21. Lye, E., Mirtsos, C., Suzuki, N., Suzuki, S., and Yeh, W.C., The role of interleukin1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 2004. 279: 40653-40658.
22. Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H. et al., Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002. 416: 750-756.
23. Picard, C., Puel, A., Bonnet, M., Ku, C. L., Bustamante, J., Yang, K., Soudais, C. et al., Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003. 299: 2076-2079.
24. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A., Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 1986. 83: 1670-1674.
25. Chen, C. Y., Gatto-Konczak, F., Wu, Z., and Karin, M., Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998. 280: 1945-1949.
26. Frevel, M. A., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S., and Williams, B. R., p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol.Cell Biol. 2003. 23: 425-436.
27. Davidson, D. J., Currie, A. J., Bowdish, D.M., Brown, K. L., Rosenberger, C. M., Ma, R. C., Bylund, J. et al., IRAK-4 mutation (Q293X): Rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells. J. Immunol. 2006. 177: 8202-8211.
28. Ku, C. L., von Bernuth, H., Picard, C., Zhang, S. Y., Chang, H. H., Yang, K., Chrabieh, M. et al., Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 2007. 204: 2407-2422.
29. Medvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C., Salkowski, C., Zhang, S., Arditi, M. et al., Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 2003. 198: 521-531.
30. Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C. L., Casrouge, A., Picard, C. et al., Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity. 2005. 23: 465-478.